Asthma is increasingly recognised as a heterogeneous disease, with several phenotypes defined by clinical and inflammatory characteristics. Common phenotypes include allergic (eosinophilic, IgE-mediated), non-allergic (often neutrophilic or paucigranulocytic), late-onset adult asthma, obesity-associated asthma, and asthma with persistent airflow limitation.14 Identifying phenotypes supports individualised treatment strategies, particularly in those with severe asthma, and better long-term outcomes.
Steps 2 and 3: Maintenance and reliever therapy (MART)
Comorbid conditions can complicate asthma management. Assess for and help address factors such as allergic rhinitis, which affects up to 80% of people with asthma,24 as well as gastro-oesophageal reflux disease (GORD), anxiety, depression, obstructive sleep apnoea and smoking.
Should cannabidiol be down-scheduled to S3?
The Therapeutic Goods Administration (TGA) has delivered an interim decision to down-schedule low dose cannabidiol.
PSA22 in pictures
Over 3 days, pharmacists gathered for a mix of learning and social events at PSA22. See if you can spot yourself in the crowd.
How GP pharmacist medicine reviews prevent hospital readmissions
When under the care of a general practice pharmacist, patients recently discharged from hospital are far less likely to re-present, according to new research.
Weight loss management
Obesity is one of the most significant public health concerns worldwide. Almost 70% of Australians and 25% of children are overweight or obese.
Telehealth medication review tips
With the advent of the COVID-19 pandemic, working as a consultant pharmacist in residential aged care facilities (RACFs) suddenly became a professional challenge for Melbourne’s Neil Petrie MPS.
What’s in the DAA?
Two pharmacists share safety risks averted by using every DAA packing check as a mini-medicine review.
